RT @ASHClinicalNews : Written in @BloodJournal : Brentuximab plus nivolumab could be an alternative to salvage chemotherapy in rel/ref Hodgki…

RT @ASHClinicalNews : Written in @BloodJournal : Brentuximab plus nivolumab could be an alternative to salvage chemotherapy in rel/ref Hodgki…

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://twitter.com/ecancer/status/968130712380600325
via IFTTT